Oxidative stress and inflammation biomarkers in the blood of patients with Huntington’s disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neurological Research

• Publication date

  2012-09-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1179/1743132812Y.0000000073PMID 22889672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activity.

  2011cited by this paper
• Important role of oxidative stress biomarkers in Huntington's disease.

  2011cited by this paper
• Inflammation and oxidative damage in Alzheimer's disease: friend or foe?

  2011cited by this paper
• Inflammation and Alzheimer’s disease

  2010cited by this paper
• Targeting Glial Cells to Elucidate the Pathogenesis of Huntington’s Disease

  2010cited by this paper
• Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

  2010cited by this paper
• Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.

  2010cited by this paper
• [The molecular bases of Huntington's disease: the role played by oxidative stress].

  2009cited by this paper
• Bases moleculares de la enfermedad de Huntington: Papel del estrés oxidativo

  2009cited by this paper
• Upper gastrointestinal findings in Huntington’s disease: patients suffer but do not complain

  2009cited by this paper
• A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

  2008cited by this paper
• Oxidative and Inflammatory Pathways in Parkinson’s Disease

  2008cited by this paper
• Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?

  2008cited by this paper
• Free Copper, Ferroxidase and SOD1 Activities, Lipid Peroxidation and NOx Content in the CSF. A Different Marker Profile in Four Neurodegenerative Diseases

  2008cited by this paper
• Immune markers for Huntington’s disease?

  2008cited by this paper
• Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

  2008cited by this paper
• Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects

  2007cited by this paper
• Mitochondrial dysfunction, oxidative stress and neurodegeneration

  2006cited by this paper
• Anticoagulants and other preanalytical factors interfere in plasma nitrate/nitrite quantification by the Griess method.

  2002cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Activated Immune System in Patients with Huntington's Disease

  1998cited by this paper
• Unified Huntington's disease rating scale: Reliability and consistency

  1996cited by this paper
• Unified Huntington's disease rating scale: reliability and consistency

  1996cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• A Two-Track Model of Huntington’s Disease Pathology: Striatal Atrophy Mediates Maladaptive Immune Dysregulation

  2026cites this paper
• Dual inhibition of canonical and noncanonical PAR‐1 by SCH79797 mitigates neurodegeneration in 3‐NP‐induced Huntington's disease: An in vivo and in silico approach

  2025cites this paper
• Neuroinflammation in Huntington's disease: Causes, consequences, and treatment strategies

  2025cites this paper
• Exploring the Pharmacological Landscape of Undaria pinnatifida: Insights into Neuroprotective Actions and Bioactive Constituents

  2025cites this paper
• C-reactive protein: the nexus between inflammation and protein misfolding diseases

  2025cites this paper
• Oxidative Stress in Huntington’s Disease

  2025cites this paper
• Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington's disease

  2024cites this paper
• The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China

  2024cites this paper
• The Role of NRF2 in Trinucleotide Repeat Expansion Disorders

  2024cites this paper
• Reconsidering red blood cells as the diagnostic potential for neurodegenerative disorders

  2024cites this paper
• New opportunities for antioxidants in amelioration of neurodegenerative diseases.

  2024cites this paper
• New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases

  2024cites this paper
• The Role of Thioredoxin System in Shank3 Mouse Model of Autism

  2024cites this paper
• Inflammation and Huntington’s disease – a neglected therapeutic target?

  2024cites this paper
• Surface modification of transition metals (TM: Mn, Fe, Co) decorated Pt-doped carbon quantum dots (Pt@CQDs) nanostructure as nonenzymatic sensors for nitrotyrosine (a biomarker for Alzheimer): Perspective from density functional theory

  2024cites this paper
• Morin post-treatment surpassed calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate/calpain axis, Kidins220, and BDNF/TrkB/AKT/CREB trajectory.

  2023cites this paper
• The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source

  2023cites this paper
• Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis.

  2023cites this paper
• Associations of Blood Inflammatory Cytokines and Hair Cortisol with Depression Symptoms and Cognitive Functioning in Huntington's Disease

  2023cites this paper
• Interleukin-6 as a marker of Huntington's disease progression: Systematic review and meta-analysis

  2023cites this paper
• Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington’s Disease Stages

  2023cites this paper
• The updated development of blood-based biomarkers for Huntington’s disease

  2023cites this paper
• A New Perspective on Huntington’s Disease: How a Neurological Disorder Influences the Peripheral Tissues

  2022cites this paper
• Role of Nrf2 in Aging, Alzheimer's and Other Neurodegenerative Diseases.

  2022cites this paper
• Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6/1 mouse model with prospects for early diagnosis and monitoring of the disease

  2022cites this paper
• Neuroprotective effects of oleuropein: Recent developments and contemporary research.

  2021cites this paper
• Metabolomics in degenerative brain diseases.

  2021cites this paper
• Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection

  2021cites this paper
• Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: Effects on cell apoptosis, oxidative stress and inflammation in the brain

  2021cites this paper
• Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis.

  2021cites this paper
• Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington’s Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31

  2021cites this paper
• Neurodegenerative Disease and the NLRP3 Inflammasome

  2021cites this paper
• The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders

  2021cites this paper
• From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders.

  2021cites this paper
• The Functions of Thioredoxin 1 in Neurodegeneration

  2021cites this paper
• Regulated cell death: discovery, features and implications for neurodegenerative diseases

  2021cites this paper
• Bioactive Peptides from Liquid Milk Protein Concentrate by Sequential Tryptic and Microbial Hydrolysis

  2021cites this paper
• Neuroprotective Effect of Antioxidants in the Brain

  2020cites this paper
• Salivary Redox Biomarkers in Selected Neurodegenerative Diseases

  2020cites this paper
• cGAS, a DNA Sensor, Promotes Inflammatory Responses in Huntington Disease

  2020cites this paper
• Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement

  2020cites this paper
• Roles of Cannabidiol in Reversing Proteinopathies

  2020cites this paper
• A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019)

  2020cites this paper
• Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease

  2020cites this paper
• Inflammation in Huntington's disease: A few new twists on an old tale.

  2020cites this paper
• Oxidant and antioxidant balance in children with bacteremia.

  2020cites this paper
• Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington’s Disease Patients and Healthy Control Subjects

  2020cites this paper
• Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study

  2020cites this paper
• Emerging potential of cannabidiol in reversing proteinopathies.

  2020cites this paper
• RNA Sequencing of Human Peripheral Blood Cells Indicates Upregulation of Immune-Related Genes in Huntington's Disease

  2020cites this paper
• C-Reactive Protein and Neurodegenerative Diseases

  2020cites this paper
• The Role of Microglia and Astrocytes in Huntington’s Disease

  2019cites this paper
• Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

  2018cites this paper
• Huntington’s Disease

  2018influential citation
• Transcriptomic Biomarkers for Huntington's Disease: Are Gene Expression Signatures in Whole Blood Reliable Biomarkers?

  2018cites this paper
• Cannabis sativa Increases Seizure Severity and Brain Lipid Peroxidation in Pentylenetetrazole-Induced Kindling in Rats

  2018cites this paper
• Cannabis Sativa Increases Seizure Severity and Brain Lipid Peroxidation in Pentylenetetrazole-Induced Kindling in Rats

  2018cites this paper
• A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward

  2018influential citation
• Thioredoxin system as a gatekeeper in caspase-6 activation and nuclear lamina integrity: Implications for Alzheimer's disease.

  2018cites this paper
• Biofluid Biomarkers in Huntington's Disease.

  2018influential citation
• Changes in the oxidative stress/anti-oxidant system after exposure to sulfur mustard and antioxidant strategies in the therapy, a review

  2017cites this paper
• Plasma Cytokine Levels in Relation to Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington’s disease

  2016cites this paper
• Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.

  2016cites this paper
• Myeloperoxidase: Bridging the gap in neurodegeneration.

  2016cites this paper
• Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington’s Disease

  2015cites this paper
• Suicidality in Huntington’s disease

  2015cites this paper
• Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.

  2015cites this paper
• Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington’s Disease

  2015cites this paper
• Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice

  2015cites this paper
• The choreography of neuroinflammation in Huntington's disease.

  2015cites this paper
• Chronic Inflammation and Innate Immunity in Alzheimer's Disease - Role of Diet

  2015cites this paper
• Interleukin 6 and cognitive dysfunction

  2014cites this paper
• Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.

  2014cites this paper
• Systemic Redox Biomarkers in Neurodegenerative Diseases.

  2014cites this paper
• Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems

  2014cites this paper
• Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases

  2014cites this paper
• Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease.

  2014cites this paper
• The role of melatonin in multiple sclerosis, Huntington's disease and cerebral ischemia.

  2014cites this paper
• Thioredoxin System Regulation in the Central Nervous System: Experimental Models and Clinical Evidence

  2014cites this paper
• Neuroprotective effect of melatonin in experimentally induced hypobaric hypoxia.

  2013cites this paper
• Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase

  2013cites this paper
• Role of oxidative stress in infectious diseases. A review

  2013cites this paper
• Assessing Competence of Broccoli Consumption on Inflammatory and Antioxidant Pathways in Restraint-Induced Models: Estimation in Rat Hippocampus and Prefrontal Cortex

  2013cites this paper
• Hypochlorous acid as a precursor of free radicals in living systems

  2013cites this paper